1-10 of 10
Stephan Kremers, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low-Dose Azacitidine, Pioglitazone and All-Trans Retinoic Acid Versus Standard-Dose Azacitidine in Patients ≥ 60 Years with Acute Myeloid Leukemia Refractory to Standard Induction Chemotherapy (AMLSG 26-16/AML-ViVA): Results of the Safety Run-in Phase I

Daniel Heudobler, Sebastian Klobuch, MD, Florian Lüke, MD, Joachim Hahn, MD, Matthias Grube, MD, Stephan Kremers, MD, Thomas Südhoff, MD, Jörg Westermann, MD, Marie-Luise Huetter-Kroenke, MD, Peter Paschka, MD, Gauthier Bouche, Hartmut Döhner, MD, Wolfgang Herr, MD, Simone Thomas, MD, Albrecht Reichle, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1382.
https://doi.org/10.1182/blood-2019-129977
Published: 2019
Journal Articles

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Uwe Platzbecker, MD, Eva Lengfelder, MD, Kerstin Schäfer-Eckart, MD, Katharina S Götze, MD, Michael Heuser, MD, Felicitas Thol, MD, Helmut R. Salih, MD, Mathias Hänel, MD, Karsten Spiekermann, Sonja Martin, MD, Sigrid Machherndl-Spandl, MD, Volker Kunzmann, MD, Andreas Jakob, MD, Hans-Joachim Tischler, MD, Dirk Niemann, MD, Joerg Mezger, MD, Tilmann Bochtler, MD, Stefan Krause, MD, Maike de Wit, MD, Claudia D. Baldus, MD, Richard Greil, MD, Jochen Greiner, Mark Ringhoffer, MD, Markus Radsak, MD, Mohammed Amen Wattad, MD, Wolff Schmiegel, MD, Elisabeth Koller, MD, Frank Heits, MD, Albrecht Reichle, MD, Stephan Kremers, MD, Andreas Hochhaus, MD, Nadezda Basara, MD, Dominik Wolf, MD, Martin Goerner, MD, Markus Schaich, MD, Harald Biersack, MD, Heinz Kirchen, MD, Thomas Kubin, MD, Gregor Aschauer, MD, Tanja Hesse, MD, Hartmut Link, MD PhD, Heinz Duerk, MDPhD, Dorit Kuerschner, MD, Walter Fiedler, MD, Bernd Hertenstein, MD, Martin Puttrich, Michael Kramer, M.Sc., Michaela Sauer, Wolfgang Hiddemann, Ulrich Duehrsen, MD, Hubert Serve, Christian Thiede, MD, Arnold Ganser, MD, Tim H. Brummendorf, MD, Konstanze Dohner, MD, Martin Bornhäuser, MD, Richard F. Schlenk, MD, Christoph Rollig, MD MSC, Hartmut Döhner, MD, Gerhard Ehninger, Peter Paschka, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2618.
https://doi.org/10.1182/blood.V130.Suppl_1.2618.2618
Published: 2017
Journal Articles

Bortezomib and Low-Dose Dexamethasone with or without Continuous Low-Dose Oral Cyclophosphamide for Primary Refractory or Relapsed Multiple Myeloma: Final Results of a National Multicenter Randomized Controlled Phase III Study

Martin Kropff, MD, Martin Vogel, MD PhD, Andrea Kreter, Dipl. Stat., Rudolf Schlag, Lothar Müller, MD, Rudolf Weide, MD, Wolfgang Knauf, MD PhD, Thomas Decker, MD, Heinrich Fiechtner, PhD, Georgi Kojouharoff, MD, Stephan Kremers, MD, Wolfgang E Berdel, MD
Journal: Blood
Blood (2014) 124 (21): 3470.
https://doi.org/10.1182/blood.V124.21.3470.3470
Published: 2014
Journal Articles

Prospective Phase III Trial Of Valproic Acid (VPA) In Combination With All-Trans Retinoic Acid (ATRA) and Intensive Induction Therapy For AML In Older Patients: Final and Molecular Subset Analyses Of The AMLSG 06-04 Study

Michela Giulia Tassara, MD, Konstanze Döhner, MD, Peter Brossart, MD, Gerhard Held, Katharina Goetze, MD, Heinz-August Horst, MD, Mark Ringhoffer, MD, Claus-Henning Kohne, MD, Stephan Kremers, MD, Aruna Raghavachar, MD, Gerald Wulf, MD, Heinz Kirchen, MD, David Nachbaur, MD, Hans-Günter Derigs, M.D., Mohammed Wattad, MD, Elisabeth Koller, MD, Wolfram Brugger, MD, Axel C. Matzdorff, MD, PhD, Richard Greil, MD, Gerhard Heil, MD, Daniela Späth, MSc, Peter Paschka, MD, Verena I. Gaidzik, MD, Martin Göttlicher, M.D., Hartmut Döhner, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2013) 122 (21): 3927.
https://doi.org/10.1182/blood.V122.21.3927.3927
Published: 2013
Journal Articles

Impact Of The Pretreatment Characteristics As Well As Cyto- and Molecular-Genetic Profile On Outcome After Relapse In Acute Myeloid Leukemia

Richard F. Schlenk, MD, Peter Frech, Sabine Kayser, MD, Daniela Späth, MSc, Peter Brossart, MD, Heinz-August Horst, MD, Doris M Kraemer, M.D., Gerhard Held, Mark Ringhoffer, MD, Alexander Burchardt, M.D., Andrea Kündgen, M.D., Katharina Goetze, MD, David Nachbaur, MD, Thomas Kindler, MD, Michael Lübbert, MD, Helmut R. Salih, MD, Hans Salwender, MD, Gerald Wulf, MD, Elisabeth Koller, MD, Mohammed Wattad, MD, Walter Fiedler, MD, Stephan Kremers, MD, Heinz Kirchen, MD, Bernd Hertenstein, MD, Peter Paschka, MD, Verena I. Gaidzik, MD, Veronica Teleanu, MD, Michael Heuser, MD, Felicitas Thol, MD, Arnold Ganser, MD, Konstanze Döhner, MD, Hartmut Döhner, MD
Journal: Blood
Blood (2013) 122 (21): 830.
https://doi.org/10.1182/blood.V122.21.830.830
Published: 2013
Journal Articles

Elderly CML Patients On Early Applied High Dose Imatinib Achieve Molecular Remissions As Fast As Younger Patients In Contrast To Patients On Standard Dose Imatinib: A Subanalysis Of The German CML-Study IV

Ulrike Proetel, MD, Nadine Pletsch, MD, Michael Lauseker, Lida Kalmanti, MD, Annette Schreiber, MD, Martin C. Müller, MD, Benjamin Hanfstein, MD, Stefan W. Krause, MD, Dominik Heim, MD, Gabriela M. Baerlocher, MD, Wolf-Karsten Hofmann, MD, Elisabeth Lange, MD, Hermann Einsele, MD, Martin Wernli, MD, Stephan Kremers, MD, Rudolf Schlag, MD, Lothar Müller, MD, Matthias Hänel, MD, Hartmut Link, MD, Bernd Hertenstein, MD, Markus Pfirrmann, PhD, Andreas Hochhaus, MD, Joerg Hasford, MD, Rüdiger Hehlmann, MD, Susanne Saussele, MD
Journal: Blood
Blood (2013) 122 (21): 96.
https://doi.org/10.1182/blood.V122.21.96.96
Published: 2013
Journal Articles

Therapy with Imatinib In Elderly CML Patients (>65years): Results of the German CML-Study IV.

Susanne Saussele, MD, Nadine Pletsch, MD, Michael Lauseker, Armin Leitner, MD, Susanne Jung-Munkwitz, MD, Ulrike Proetel, MD, Martin C. Müller, MD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD, PhD, Gerhard Ehninger, MD, Dieter K. Hossfeld, MD, Stefan W. Krause, MD, Christoph Nerl, MD, PhD, Hans Pralle, MD, Dominik Heim, MD, Gabriela M. Baerlocher, MD, Leopold Balleisen, MD, Hermann Einsele, MD, Anthony D. Ho, MD, FRCPC, Christiane Falge, MD, Matthias Hänel, MD, M. Pfreundschuh, Lothar Kanz, MD, Frank Stegelmann, MD, Claus-Henning Köhne, MD, Stephan Kremers, MD, Karsten Spiekermann, MD, Steffen Koschmieder, MD, Cornelius F. Waller, MD, Martin Bentz, MD, Markus Pfirrmann, PhD, Andreas Hochhaus, Jörg Hasford, MD, Rüdiger Hehlmann, MD, for The German CML-Study Group
Journal: Blood
Blood (2010) 116 (21): 3411.
https://doi.org/10.1182/blood.V116.21.3411.3411
Published: 2010
Journal Articles

Isocitrate Dehydrogenase Gene Mutations In Elderly Patients with Acute Myeloid Leukemia (AML) and Outcome After Treatment with All-Trans Retinoic Acid: A Study of the German-Austrian AML Study Group (AMSLG)

Peter Paschka, MD, Richard F. Schlenk, MD, Mariam Ibañez, Alexandra Kagias, Lars Bullinger, MD, Verena I. Gaidzik, MD, Daniela Späth, Heinz A. Horst, MD, PhD, Gerhard Held, MD, Martin Bentz, MD, Stephan Kremers, MD, Richard Greil, MD, Mohammed Wattad, MD, Wolfram Brugger, MD, PhD, Volker Runde, MD, Aruna Raghavachar, MD, Hans-Guenter Derigs, Heinrich Kirchen, MD, Hartmut Döhner, MD, Konstanze Döhner, MD
Journal: Blood
Blood (2010) 116 (21): 101.
https://doi.org/10.1182/blood.V116.21.101.101
Published: 2010
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Richard F. Schlenk, MD, Konstanze Dohner, MD, Martina Kerz, Francisco del Valle, MD, Björn Heydrich, MD, Ingo Schmidt-Wolf, MD, Hans Pralle, MD, Katharina Götze, MD, Elisabeth Koller, MD, David Nachbaur, MD, Hans G. Mergenthaler, MD, Walter Fiedler, MD, Detlef Haase, MD, Stephan Kremers, MD, Matthias Theobald, MD, Axel Matzdorff, MD, Arnold Ganser, MD, Hartmut Dohner, MD
Journal: Blood
Blood (2006) 108 (11): 1949.
https://doi.org/10.1182/blood.V108.11.1949.1949
Published: 2006
Journal Articles

All-Trans Retinoic Acid and Gemtuzumab Ozogamicin as Adjunct To Salvage Therapy in Primary Refractory Acute Myeloid Leukemia: Results of Consecutive Phase II Studies of the AMLSG.

Richard F. Schlenk, MD, Konstanze Doehner, MD, Martina Kerz, Frank Hartmann, MD, Francesco del Valle, MD, Axel Glasmacher, MD, Hans Pralle, MD, Katharina Goetze, MD, Elisabeth Koller, MD, Guenther Gastl, MD, Hans G. Mergenthaler, MD, Hans Salwender, MD, Heinz Kirchen, MD, Detlef Haase, MD, Stephan Kremers, MD, Christoph Nerl, MD, Matthias Theobald, MD, Axel C. Matzdorff, MD, Arnold Ganser, MD, Hartmut Doehner, MD, for the German-Austrian, AML Study Group (AMLSG)
Journal: Blood
Blood (2005) 106 (11): 1849.
https://doi.org/10.1182/blood.V106.11.1849.1849
Published: 2005